Reducing drug spend is one of the greatest challenges for practices participating in the Oncology Care Model (OCM). Evidence-based clinical pathways have the potential to decrease drug spend while ...

Electrochemical hydrogenation (ECH) of biomass-derived platform molecules is a burgeoning route for the sustainable utilization of hydrogen, as the active hydrogen in-situ generated on the ...

During the pandemic, the Centers for Medicare & Medicaid Services (CMS) gave Oncology Care Model (OCM) practices the opportunity to "forgo upside and downside risk for performance periods" and floated ...

However, given the rising treatment costs and increasingly precise standards of care for differentiated disease phenotypes within NSCLC, it is worth reexamining the extent to which clinical pathways ...

According to the 2011Managed Care Benefit Design Index, cancer was the top-ranked management priority among payers (). Mark Zitter, CEO, The Zitter Group, explained the reason for their concern: ...